MCID: NTR003
MIFTS: 56

Natural Killer Cell Leukemia malady

Rare diseases, Blood diseases, Cancer diseases, Immune diseases categories

Summaries for Natural Killer Cell Leukemia

About this section


MalaCards based summary: Natural Killer Cell Leukemia, also known as aggressive nk-cell leukemia, is related to leukemia and vascular disease. An important gene associated with Natural Killer Cell Leukemia is B3GAT1 (beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)), and among its related pathways are Busulfan Pathway, Pharmacodynamics and IL2 signaling events mediated by PI3K. The compounds topotecan and okt3 have been mentioned in the context of this disorder. Affiliated tissues include nk cells, bone and bone marrow, and related mouse phenotypes are no phenotypic analysis and tumorigenesis.

Aliases & Classifications for Natural Killer Cell Leukemia

About this section
Sources:
10Disease Ontology, 62UMLS, 49Orphanet, 43NIH Rare Diseases, 57SNOMED-CT, 40NCIt, 28ICD10 via Orphanet, 63UMLS via Orphanet
See all sources

Natural Killer Cell Leukemia, Aliases & Descriptions:

Name: Natural Killer Cell Leukemia 10 62
Aggressive Nk-Cell Leukemia 10 49 62
Leukemia, Natural Killer Cell Large Granular Lymphocytic 62
Large Granular Lymphocyte Leukemia, Nk-Cell Type 10
Chronic Lymphoproliferative Disorder of Nk-Cells 62
Nk-Cell Large Granular Lymphocyte Leukemia 49
Aggressive Natural Killer Cell Leukemia 43
 
Aggressive Natural Killer-Cell Leukemia 62
Aggressive Non-Hodgkin Lymphoma 62
Aggressive Nk Cell Leukemia 43
Aggressive Nk-Cell Lymphoma 49
Nk-Cell Lgl Leukemia 49
Ankcl 49
Ankl 43


Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Rare diseases, Cancer diseases
Anatomical: Blood diseases, Immune diseases


Characteristics (Orphanet epidemiological data):

49
aggressive nk-cell leukemia:
Age of onset: Adult; Age of death: adult


External Ids:

Disease Ontology10 DOID:1035
NCIt40 C8647
Orphanet49 86873
SNOMED-CT57 128833001
ICD10 via Orphanet28 C91.7
UMLS via Orphanet63 C1292777

Related Diseases for Natural Killer Cell Leukemia

About this section

Diseases related to Natural Killer Cell Leukemia via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 371)
idRelated DiseaseScoreTop Affiliating Genes
1leukemia31.5CD79A, MPO, TP53, EPO, IFNG, IL7
2vascular disease30.5BCL2L1, BCL2, TP53
3peripheral vascular disease30.4MPO, CD79A
4tuberculosis30.1CD79A, IL7, IFNG
5rheumatoid arthritis30.0MPO, IFNG, IL7, B3GAT1, CD79A
6systemic lupus erythematosus29.7CD79A, IFNG, MPO
7melanoma29.6TP53, IFNG, IL7, BCL2, BCL2L1
8arthropathy10.7
9spasticity10.7
10synovitis10.6
11pigmented villonodular synovitis10.6
12villonodular synovitis10.6
13cerebritis10.5
14cerebral palsy10.5
15hemiplegia10.5
16spastic cerebral palsy10.4
17synovial chondromatosis10.4
18arthritis10.4
19composite lymphoma10.4
20neuropathy10.4
21peripheral neuropathy10.4
22large granular lymphocyte leukemia10.4
23spastic diplegia10.4
24foot drop10.4
25charcot-marie-tooth disease10.4
26tooth disease10.4
27clubfoot10.3
28osteoarthritis10.3
29artery disease10.3
30atherosclerosis10.3
31hemarthrosis10.3
32arteriosclerosis10.3
33osteochondritis dissecans10.3
34ischemia10.3
35common variable immunodeficiency10.3
36hematopoietic stem cell transplantation10.3
37hemophagocytic lymphohistiocytosis10.3
38hepatitis10.3
39malignant histiocytosis10.3
40histiocytosis10.3
41meningitis10.3
42nephrotic syndrome10.3
43limb ischemia10.2
44tarsal tunnel syndrome10.2
45compartment syndrome10.2
46exostosis10.2
47hemophilic arthropathy10.2
48critical limb ischemia10.2
49intermittent claudication10.2
50peripheral artery disease10.2

Graphical network of the top 20 diseases related to Natural Killer Cell Leukemia:



Diseases related to natural killer cell leukemia

Symptoms for Natural Killer Cell Leukemia

About this section

Drugs & Therapeutics for Natural Killer Cell Leukemia

About this section

Drug clinical trials:

Search ClinicalTrials for Natural Killer Cell Leukemia

Search NIH Clinical Center for Natural Killer Cell Leukemia

Genetic Tests for Natural Killer Cell Leukemia

About this section

Anatomical Context for Natural Killer Cell Leukemia

About this section

MalaCards organs/tissues related to Natural Killer Cell Leukemia:

33
Nk cells, Bone, Bone marrow, Myeloid, T cells

Animal Models for Natural Killer Cell Leukemia or affiliated genes

About this section

MGI Mouse Phenotypes related to Natural Killer Cell Leukemia:

37 (show all 11)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00030128.3CD79A, IL7, IFNG, TP53
2MP:00020068.1BCL2L1, BCL2, IFNG, TP53
3MP:00053678.0CD79A, BCL2, IFNG, TP53
4MP:00107717.7TP53, EPO, IFNG, BCL2, BCL2L1
5MP:00053857.6MPO, TP53, EPO, IFNG, BCL2
6MP:00036317.4TP53, IFNG, BCL2, BCL2L1, B3GAT1, CD79A
7MP:00053847.3TP53, EPO, IFNG, BCL2, BCL2L1, CD79A
8MP:00053877.1MPO, TP53, IFNG, IL7, BCL2, BCL2L1
9MP:00053766.9MPO, TP53, EPO, IFNG, BCL2, BCL2L1
10MP:00107686.8MPO, TP53, EPO, IFNG, BCL2, BCL2L1
11MP:00053976.6CD79A, MPO, TP53, EPO, IFNG, IL7

Publications for Natural Killer Cell Leukemia

About this section

Articles related to Natural Killer Cell Leukemia:

(show top 50)    (show all 60)
idTitleAuthorsYear
1
Rare aggressive natural killer cell leukemia presented with bone marrow fibrosis - a diagnostic challenge. (25126488)
2014
2
Six cases of aggressive natural killer-cell leukemia in a Chinese population. (25031771)
2014
3
Aggressive natural killer-cell leukemia: classical presentation of a rare disease. (25118753)
2014
4
Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia. (24524877)
2014
5
Adult aggressive natural killer cell leukemia. (23241562)
2013
6
Aggressive natural killer-cell leukemia with jaundice and spontaneous splenic rupture: a case report and review of the literature. (23510456)
2013
7
Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia. (23181473)
2013
8
A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma. (24427365)
2013
9
Anti-cancer activity of gemcitabine against natural killer cell leukemia/lymphoma. (23772641)
2013
10
Successful disease control with L-asparaginase monotherapy for aggressive natural killer cell leukemia with severe hepatic failure. (22891745)
2013
11
Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation. (22360679)
2012
12
Three cases of aggressive natural killer cell leukemia with a lethal hemorrhagic complication. (23037625)
2012
13
Collapsing glomerulopathy associated with natural killer cell leukemia: a case report and review of the literature. (21908087)
2011
14
Sustained CR of refractory aggressive natural killer cell leukemia following unrelated cord blood transplantation. (20676148)
2010
15
Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker. (20046078)
2009
16
Epstein-Barr virus-associated proliferative disorder presenting as Hodgkin's lymphoma and developing as aggressive natural killer-cell leukemia 19 years later: a case report of composite lymphoma. (19269751)
2009
17
A case of natural killer cell leukemia misdiagnosed as tuberculous lymphadenopathy. (19571615)
2009
18
Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis? (19153474)
2008
19
Aggressive natural killer cell leukemia presenting with hemophagocytic lymphohistiocytosis. (17853464)
2008
20
Precursor natural killer cell leukemia. (17417789)
2008
21
Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature. (17261497)
2007
22
Aggressive natural killer cell leukemia in a patient with common variable immunodeficiency syndrome. (16785152)
2006
23
Retroviral expression screening of oncogenes in natural killer cell leukemia. (15978945)
2005
24
Aggressive Natural Killer-Cell Leukemia: report of five cases and review of the literature. (15621755)
2004
25
Aggressive natural killer cell leukemia/lymphoma: case report, use of telesynergy and review of the literature. (15360011)
2004
26
Marked elevation of soluble fas ligand and cytokine secretion after splenectomy in aggressive natural killer cell leukemia/lymphoma. (15512819)
2004
27
Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. (14961041)
2004
28
Unusual lymphoma manifestations: case 1. Natural killer cell leukemia with dermal erythema and vascular epidermal growth factor production. (14752078)
2004
29
Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma. (12543867)
2003
30
Large granular lymphocyte leukemia and natural killer cell leukemia/lymphomas. (12943609)
2003
31
Aggressive natural killer cell leukemia: clinical features and treatment outcome. (12495907)
2002
32
Comprehensive cytogenetic study by spectral karyotyping on blastic natural killer cell leukemia/lymphoma. (11891818)
2002
33
Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. (11568749)
2001
34
Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia. (11779295)
2001
35
Long-term remission induced by corticosteroids, cyclophosphamide, and methotrexate in a patient with natural killer cell leukemia. (10696134)
2000
36
Aggressive natural killer cell leukemia/lymphoma: a comprehensive cytogenetic study by spectral karyotyping. (11043424)
2000
37
Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma. (10803505)
2000
38
Epstein-Barr virus-infected natural killer cell leukemia. (11426629)
2000
39
Blastoid natural killer cell leukemia. (10439811)
1999
40
Interferon-gamma prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. (10233902)
1999
41
Natural killer cell leukemia as a cause of peripheral neuropathy and meningitis: case report. (9710063)
1998
42
Aggressive natural killer cell leukemia: report of a case in a Caucasian boy. (9549932)
1998
43
Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. (9331296)
1997
44
Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. (8599969)
1996
45
Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents. (7736391)
1995
46
Recognition of unusual presentation of natural killer cell leukemia. (7572992)
1995
47
Natural killer cell leukemia. An autopsy case. (7979914)
1994
48
Natural killer cell leukemia presenting with a peripheral neuropathy. (8414048)
1993
49
Cytokine levels in aggressive natural killer cell leukemia and malignant histiocytosis. (1911378)
1991
50
Hematopoiesis in patients with acute natural killer cell leukemia and large granular lymphocytosis: relationship between clinical features and hematopoietic inhibitor activity of peripheral mononuclear cells. (2806481)
1989

Variations for Natural Killer Cell Leukemia

About this section

Expression for genes affiliated with Natural Killer Cell Leukemia

About this section

Search GEO for disease gene expression data for Natural Killer Cell Leukemia.

Pathways for genes affiliated with Natural Killer Cell Leukemia

About this section

Pathways related to Natural Killer Cell Leukemia according to GeneCards/GeneDecks:

(show all 43)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
Catalytic cycle of mammalian FMOs38
9.4BCL2, BCL2L1
2
Show member pathways
IL2 signaling events mediated by STAT538
9.4BCL2L1, BCL2
3
Show member pathways
9.4BCL2L1, BCL2
49.4BCL2L1, BCL2
5
Show member pathways
Apoptosis and survival Anti apoptotic TNFs NF kB IAP pathway60
9.4BCL2L1, BCL2
69.3BCL2, IFNG
7
Show member pathways
9.3IFNG, BCL2
8
Show member pathways
Development Thrombopoetin signaling via JAK STAT pathway60
9.3BCL2L1, IFNG
99.2EPO, TP53
109.1BCL2, TP53
11
Show member pathways
9.1TP53, BCL2
129.1TP53, BCL2
13
Show member pathways
9.1BCL2L1, BCL2, IL7
14
Show member pathways
EPO Receptor Signaling38
EPO signaling pathway38
9.0EPO, BCL2, BCL2L1
158.9EPO, IFNG, BCL2
168.8IFNG, BCL2, BCL2L1
17
Show member pathways
8.8IFNG, BCL2, BCL2L1
188.7BCL2L1, TP53, MPO
19
Show member pathways
Apoptosis and survival TNFR1 signaling pathway60
TWEAK Signaling Pathway38
Apoptosis Modulation by HSP7038
HIV-1 Nef- Negative effector of Fas and TNF-alpha38
8.6BCL2L1, BCL2, TP53
208.6BCL2L1, BCL2, TP53
21
Show member pathways
Development EGFR signaling via PIP360
Development PDGF signaling via MAPK cascades60
Apoptosis and survival Anti apoptotic action of membrane bound ESR160
Signaling of Hepatocyte Growth Factor Receptor38
Development EGFR signaling via small GTPases60
Development Neurotrophin family signaling60
Apoptosis and survival NGF signaling pathway60
Apoptosis and survival Role of CDK5 in neuronal death and survival60
8.6BCL2L1, BCL2, TP53
22
Show member pathways
8.6TP53, BCL2, BCL2L1
23
Show member pathways
8.6TP53, BCL2, BCL2L1
24
Show member pathways
Apoptosis and survival Apoptotic TNF family pathways60
8.6TP53, BCL2, BCL2L1
25
Show member pathways
Amyotrophic lateral sclerosis (ALS)38
8.6TP53, BCL2, BCL2L1
26
Show member pathways
8.6BCL2L1, BCL2, TP53
27
Show member pathways
8.6BCL2L1, BCL2, TP53
288.6BCL2L1, BCL2, TP53
29
Show member pathways
Apoptosis Modulation and Signaling38
Apoptosis38
8.6TP53, BCL2, BCL2L1
30
Show member pathways
8.6BCL2L1, BCL2, TP53
31
Show member pathways
Type III interferon signaling38
8.5BCL2L1, IL7, IFNG, EPO
328.5BCL2, IFNG, TP53
338.5BCL2, IFNG, TP53
34
Show member pathways
Toll-like receptor signaling pathway38
Regulation of toll-like receptor signaling pathway38
8.5BCL2, IFNG, TP53
358.5TP53, IFNG, BCL2L1
36
Show member pathways
IL23-mediated signaling events38
Immune response IL 10 signaling pathway60
Angiopoietin receptor Tie2-mediated signaling38
Development PDGF signaling via STATs and NF kB60
Development Angiopoietin Tie2 signaling60
8.4BCL2L1, BCL2, IFNG, MPO
37
Show member pathways
8.3TP53, IL7, BCL2, BCL2L1
38
Show member pathways
8.2CD79A, BCL2L1, BCL2, TP53
39
Show member pathways
8.1CD79A, BCL2, IFNG, TP53
40
Show member pathways
Proteasome Degradation38
Immune response Antigen presentation by MHC class I60
8.0TP53, IFNG, BCL2, BCL2L1
417.8TP53, EPO, IL7, BCL2, BCL2L1
42
Show member pathways
7.7TP53, EPO, IFNG, IL7, BCL2
43
Show member pathways
7.2TP53, EPO, IFNG, IL7, BCL2, BCL2L1

Compounds for genes affiliated with Natural Killer Cell Leukemia

About this section

Compounds related to Natural Killer Cell Leukemia according to GeneCards/GeneDecks:

(show top 50)    (show all 157)
idCompoundScoreTop Affiliating Genes
1topotecan45 1310.9EPO, BCL2L1
2okt3459.5CD79A, IL7, IFNG
3at 101619.4BCL2L1, BCL2
43-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide459.4BCL2L1, BCL2, IL7
5methylcellulose459.3EPO, IFNG, IL7
6gm-csf45 3010.2BCL2L1, EPO, IFNG
7staurosporin459.2BCL2, BCL2L1, IFNG
8mycophenolate mofetil45 51 1311.2CD79A, IFNG, EPO
910-hydroxycamptothecin459.0BCL2, TP53, BCL2L1
107-hydroxystaurosporine45 1310.0BCL2L1, BCL2, TP53
11chlorambucil45 1310.0BCL2, TP53, BCL2L1
12z-vad-fmk45 6110.0BCL2L1, BCL2, TP53
13sulindac sulfide459.0BCL2L1, TP53, BCL2
14noxa459.0TP53, BCL2, BCL2L1
15cd 437459.0TP53, BCL2, BCL2L1
16indole-3-carbinol458.9BCL2L1, BCL2, TP53
17dutp458.9TP53, BCL2L1, BCL2
18sulindac45 139.9BCL2, BCL2L1, TP53
19depsipeptide458.9TP53, BCL2L1, BCL2
20triptolide458.9BCL2, IFNG, TP53
212-methoxyestradiol45 61 2610.8BCL2, TP53, BCL2L1
22parthenolide45 39.8TP53, IFNG, BCL2L1
23histamine45 30 2610.8B3GAT1, MPO, IFNG, IL7, CD79A
24n-(4-hydroxyphenyl)retinamide458.8TP53, BCL2, BCL2L1
25cyclophosphamide45 51 1310.8TP53, MPO, BCL2, IL7
26roscovitine458.7BCL2L1, TP53, BCL2
27oxaliplatin45 51 1310.6BCL2L1, MPO, TP53
28fludarabine45 51 1310.6BCL2L1, TP53, BCL2
29phosphatidylserine45 30 1310.6BCL2, TP53, BCL2L1, CD79A
30rapamycin458.4EPO, IFNG, IL7, BCL2L1, BCL2
31suberoylanilide hydroxamic acid458.4BCL2L1, BCL2, IFNG, TP53
32pdtc458.4TP53, BCL2L1, IFNG, BCL2
33lactacystin458.4TP53, IFNG, BCL2, BCL2L1
34dexamethasone45 51 30 1311.3BCL2, IL7, IFNG, CD79A, BCL2L1
35flavopiridol45 139.3BCL2L1, BCL2, TP53
36retinoid458.3BCL2L1, IFNG, TP53, BCL2
37n acetylcysteine458.3TP53, BCL2, BCL2L1, CD79A, MPO
38paraffin458.2TP53, BCL2, CD79A, BCL2L1, MPO
39cytarabine45 51 1310.2TP53, EPO, BCL2, MPO, BCL2L1
40h2o2458.2CD79A, BCL2L1, BCL2, TP53, MPO
41cisplatin45 51 61 1311.1TP53, BCL2L1, BCL2, EPO, MPO
42melphalan45 51 1310.1EPO, IFNG, BCL2L1, CD79A, TP53
43sb 20358045 619.1TP53, IFNG, BCL2, BCL2L1
44carboplatin45 51 1310.1MPO, TP53, BCL2, IFNG, EPO
45cycloheximide458.0IL7, BCL2L1, BCL2, TP53, IFNG
465fluorouracil458.0TP53, MPO, IFNG, BCL2L1, BCL2
47estrogen458.0TP53, IL7, BCL2, BCL2L1, B3GAT1, CD79A
48butyrate457.6IFNG, EPO, TP53, MPO, BCL2, BCL2L1
49retinoic acid45 268.3IFNG, BCL2, CD79A, BCL2L1, IL7, TP53
50vegf456.9CD79A, MPO, TP53, EPO, IFNG, IL7

GO Terms for genes affiliated with Natural Killer Cell Leukemia

About this section

Cellular components related to Natural Killer Cell Leukemia according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00056158.3IL7, IFNG, EPO, MPO
2mitochondrionGO:00057398.2BCL2L1, BCL2, TP53, MPO

Biological processes related to Natural Killer Cell Leukemia according to GeneCards/GeneDecks:

(show all 36)
idNameGO IDScoreTop Affiliating Genes
1homeostasis of number of cells within a tissueGO:00488739.9IL7, BCL2
2negative regulation of calcium ion transport into cytosolGO:00105239.9EPO, BCL2
3B cell proliferationGO:00421009.8CD79A, BCL2
4negative regulation of growth of symbiont in hostGO:00441309.8MPO, IFNG
5B cell receptor signaling pathwayGO:00508539.8CD79A, BCL2
6negative regulation of anoikisGO:020008119.8BCL2, BCL2L1
7negative regulation of autophagyGO:00105079.8BCL2, BCL2L1
8positive regulation of B cell proliferationGO:00308909.8BCL2, IL7
9regulation of mitochondrial membrane potentialGO:00518819.7BCL2L1, BCL2
10negative regulation of intrinsic apoptotic signaling pathwayGO:020012439.7BCL2L1, BCL2
11T cell lineage commitmentGO:00023609.7TP53, IL7
12response to salt stressGO:00096519.6EPO, TP53
13extrinsic apoptotic signaling pathway in absence of ligandGO:00971929.5BCL2L1, BCL2
14B cell lineage commitmentGO:00023269.5BCL2, TP53
15ovarian follicle developmentGO:00015419.5BCL2, BCL2L1
16negative regulation of extrinsic apoptotic signaling pathway in absence of ligandGO:020012409.5IL7, BCL2, BCL2L1
17cellular response to glucose starvationGO:00421499.5TP53, BCL2
18response to ischemiaGO:00029319.5TP53, BCL2
19nucleotide-binding domain, leucine rich repeat containing receptor signaling pathwayGO:00358729.4BCL2L1, BCL2
20cell agingGO:00075699.4TP53, BCL2
21positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathwayGO:019007409.4BCL2, TP53
22humoral immune responseGO:00069599.4BCL2, IL7, IFNG
23response to gamma radiationGO:00103329.4TP53, BCL2
24response to cytokineGO:00340979.3BCL2L1, BCL2
25protein import into nucleus, translocationGO:00000609.3IFNG, TP53
26T cell differentiation in thymusGO:00330779.3TP53, BCL2
27positive regulation of cell proliferationGO:00082849.2BCL2L1, IL7, EPO
28intrinsic apoptotic signaling pathway in response to DNA damageGO:00086309.1BCL2, BCL2L1
29cellular response to hypoxiaGO:00714569.0TP53, EPO, BCL2
30regulation of mitochondrial membrane permeabilityGO:00469029.0BCL2L1, BCL2, TP53
31release of cytochrome c from mitochondriaGO:00018369.0BCL2L1, BCL2, TP53
32positive regulation of intrinsic apoptotic signaling pathwayGO:020012449.0TP53, BCL2, BCL2L1
33neuron apoptotic processGO:00514029.0BCL2L1, BCL2, TP53
34intrinsic apoptotic signaling pathwayGO:00971939.0TP53, BCL2, BCL2L1
35negative regulation of apoptotic processGO:00430668.3MPO, TP53, IL7, BCL2, BCL2L1
36apoptotic processGO:00069157.9TP53, EPO, IFNG, BCL2, BCL2L1

Molecular functions related to Natural Killer Cell Leukemia according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1BH3 domain bindingGO:00514349.3BCL2L1, BCL2
2protein phosphatase 2A bindingGO:00517218.8BCL2, TP53
3protein heterodimerization activityGO:00469828.6BCL2L1, BCL2, TP53

Products for genes affiliated with Natural Killer Cell Leukemia

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Natural Killer Cell Leukemia

About this section
4CDC
15ExPASy
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
52PubMed
53QIAGEN
58SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet